ULTRAGENYX PHARMACEUTICAL INC COM USD0.001 earnings per share and revenue

0LIF earnings per share for the last quarter are -2.03 USD whereas the estimation was -1.75 USD which accounts for -16.19% surprise. Företagets omsättning för samma period uppgår till 108.83 M USD trots den uppskattade siffran 116.03 M USD. Estimated earnings per share for the next quarter are -1.66 USD, and revenue is expected to reach 123.20 M USD. Also watch annual changes over time to get a bigger picture of 0LIF earnings per share and revenue dynamics.